Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Derakhshan, Arash ^a   Sardarinia, Mahsa ^a   Khalili, Davood ^a   Momenan, Amir Abbas ^a   Azizi, Fereidoun ^b   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNIC GROUP; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INCIDENCE; IRAN; IRANIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STANDARDIZATION; WRIST CIRCUMFERENCE; ANATOMY AND HISTOLOGY; ANTHROPOMETRY; DIABETES MELLITUS, TYPE 2; PROPORTIONAL HAZARDS MODEL; WAIST TO HEIGHT RATIO; WRIST;

ADULT; ANTHROPOMETRY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; WAIST-HEIGHT RATIO; WRIST;

EID: 84904353112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102563     Document Type: Article

References (56)

1. Magee MJ, Narayan KM (2013) Global confluence of infectious and non-communicable diseases - The case of type 2 diabetes. Prev Med.
2. Ginter E, Simko V (2012) Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol 771: 42-50.
3. Yoon U, Kwok LL, Magkidis A (2013) Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 62: 303-314.
4. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A (2012) Trends in prevalence of diabetes in Asian countries. World J Diabetes 3: 110-117.
5. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, et al. (2009) Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). Journal of endocrinological investigation 32: 724-730.
6. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes care 27: 1047-1053. (Pubitemid 38579764)
7. Green A, Christian Hirsch N, Pramming SK (2003) The changing world demography of type 2 diabetes. Diabetes Metab Res Rev 19: 3-7. (Pubitemid 36285370)
8. Herman WH, Zimmet P (2012) Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes care 35: 943-944.
9. Harati H, Hadaegh F, Saadat N, Azizi F (2009) Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC public health 9: 186.
10. Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F (2009) Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health 9: 426.
11. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, et al. (2002) Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 162: 82-89. (Pubitemid 34073405)
12. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, et al. (2007) Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30: 854-860. (Pubitemid 46556577)
13. Auryan S, Itamar R (2008) Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes, Obesity and Metabolism 10: 1135-1156.
14. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, et al. (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10: 5.
15. Association AD (2013) Standards of Medical Care in Diabetes-2013. Diabetes Care 36: S11-S66.
16. Bozorgmanesh M, Hadaegh F, Saadat N, Azizi F (2012) Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study. Acta Diabetol 49: 341-348.
17. Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F (2012) Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. Journal of endocrinological investigation 35: 14-20.
18. Committee IR (2005) Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ)-Short and long forms. Retrieved September 17: 2008.
19. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, et al. (2013) Incidence of Metabolic Syndrome over 9 Years Follow-Up; the Importance of Sex Differences in the Role of Insulin Resistance and Other Risk Factors. PloS one 8: e76304.
20. Goto A, Goto M, Noda M, Tsugane S (2013) Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis. PLoS One 8: e74699.
21. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53: 1782-1789. (Pubitemid 38857036)
22. Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30: 2258-2263. (Pubitemid 47359028)
23. Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, et al. (2013) The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab 15: 844-852.
24. Mohan V, Deepa M, Anjana RM, Lanthorn H, Deepa R (2008) Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19). J Assoc Physicians India 56: 152-157.
25. Ghassemi H, Harrison G, Mohammad K (2002) An accelerated nutrition transition in Iran. Public Health Nutr 5: 149-155. (Pubitemid 41128301)
26. Bennet L, Groop L, Lindblad U, Agardh CD, Franks PW (2014) Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: A cross sectional study comparing immigrants from the Middle East and native Swedes. Prim Care Diabetes.
27. Raaschou-Nielsen O, Andersen ZJ, Beelen R, Samoli E, Stafoggia M, et al. (2013) Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 14: 813-822.
28. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338: b880.
29. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, et al. (2008) Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia The Australian Diabetes, Obesity and Lifestyle Study. Diabetes care 31: 267-272. (Pubitemid 351213333)
30. Strandberg AY, Pienimaki T, Pitkala KH, Tilvis RS, Salomaa VV, et al. (2013) Comparison of normal fasting and one-hour glucose levels as predictors of future diabetes during a 34-year follow-up. Ann Med 45: 336-340.
31. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. The Lancet 373: 2215-2221.
32. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. The Lancet 378: 31-40.
33. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, et al. (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167: 1068-1074. (Pubitemid 46835795)
34. Noto D, Cefalu AB, Barbagallo CM, Falletta A, Ganci A, et al. (2012) Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study. Acta Diabetol 49: 145-151.
35. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, et al. (1997) Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation 96: 308-315. (Pubitemid 27298437)
36. Berns MA, de Vries JH, Katan MB (1988) Determinants of the increase of serum cholesterol with age: a longitudinal study. International journal of epidemiology 17: 789-796. (Pubitemid 19042019)
37. Greenfield MS, Kraemer F, Tobey T, Reaven G (1980) Effect of age on plasma triglyceride concentrations in man. Metabolism 29: 1095-1099. (Pubitemid 11232206)
38. Vazquez G, Duval S, Jacobs DR, Silventoinen K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiologic Reviews 29: 115-128. (Pubitemid 47229644)
39. Jensen MD (2006) Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity 14: 20S-24S.
40. Hadaegh F, Zabetian A, Harati H, Azizi F (2007) The prospective association of general and central obesity variables with incident type 2 diabetes in adults, Tehran lipid and glucose study. Diabetes Res Clin Pract 76: 449-454. (Pubitemid 46482723)
41. Qiao Q, Nyamdorj R (2009) Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index&quest. European journal of clinical nutrition 64: 30-34.
42. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, et al. (2012) Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol 176: 959-969.
43. Meisinger C, Doring A, Thorand B, Heier M, Lowel H (2006) Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 84: 483-489. (Pubitemid 44713396)
44. Li C, Ford ES, Zhao G, Kahn HS, Mokdad AH (2010) Waist-to-thigh ratio and diabetes among US adults: the Third National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 89: 79-87.
45. Schulze MB, Heidemann C, Schienkiewitz A, Bergmann MM, Hoffmann K, et al. (2006) Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care 29: 1921-1923. (Pubitemid 44156654)
46. Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, et al. (2012) Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med 9: e1001230.
47. Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F (2011) Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study. Diabetic Medicine 28: 1330-1336.
48. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, et al. (2003) Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. The American Journal of Clinical Nutrition 77: 1192-1197. (Pubitemid 44858435)
49. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, et al. (2013) Wrist circumference as a novel predictor of diabetes and prediabetes: results of cross-sectional and 8.8-year follow-up studies. The Journal of Clinical Endocrinology & Metabolism 98: 777-784.
50. Williams ED, Tapp RJ, Magliano DJ, Shaw JE, Zimmet PZ, et al. (2010) Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia 53: 2538-2545.
51. Robbins JM, Vaccarino V, Zhang H, Kasl SV (2005) Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract 68: 230-236. (Pubitemid 40775990)
52. Agardh EE, Ahlbom A, Andersson T, Efendic S, Grill V, et al. (2007) Socioeconomic position at three points in life in association with type 2 diabetes and impaired glucose tolerance in middle-aged Swedish men and women. Int J Epidemiol 36: 84-92. (Pubitemid 47061579)
53. Gill JM, Cooper AR (2008) Physical activity and prevention of type 2 diabetes mellitus. Sports Med 38: 807-824.
54. Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A, et al. (2011) Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). J Phys Act Health 8: 27-35.
55. Sullivan LM, Massaro JM, D'Agostino RB (2004) Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Statistics in medicine 23: 1631-1660. (Pubitemid 38660414)
56. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, et al. (2009) Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 9: 167.